SPOTLIGHT -
Slideshow
Author(s):
Following TBI, cognitive deficits, comorbid medical and neurological problems, as well as complex pharmacotherapeutic needs and sensitivities frequently complicate evaluation and treatment of psychosis in this population.
Novel PDE10A Inhibitor for Acute Schizophrenia Exacerbation Presented at APA Annual Meeting
Treating ‘Morally Objectionable’ Patients
Recognizing Stroke: Why Knowing the Signs Can Save Lives
What Will the Future of Alzheimer Disease Treatment Look Like?
Antipsychotics and the QTc Interval During Delirium in the Intensive Care Unit: A Secondary Analysis of a Randomized Clinical Trial
The Dawn of a New Era for Schizophrenia